Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (16)

2024

  1. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Dietary phosphate restriction prevents the appearance of sarcopenia signs in old mice

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 14, Núm. 2, pp. 1060-1074

  2. Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure

    Nutrients, Vol. 15, Núm. 8

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  2. Vitamin D Treatment Prevents Uremia-Induced Reductions in Aortic microRNA-145 Attenuating Osteogenic Differentiation despite Hyperphosphatemia

    Nutrients, Vol. 14, Núm. 13

2021

  1. Aging-related hyperphosphatemia impairs myogenic differentiation and enhances fibrosis in skeletal muscle

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 12, Núm. 5, pp. 1266-1279

  2. Contribution of phosphorus and PTH to the development of cardiac hypertrophy and fibrosis in an experimental model of chronic renal failure

    Nefrologia, Vol. 41, Núm. 6, pp. 640-651

  3. Effects of calcitriol and paricalcitol on renal fibrosis in CKD

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, Núm. 5, pp. 793-803

  4. Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders

    Calcified Tissue International, Vol. 108, Núm. 4, pp. 439-451

  5. Uraemic toxins impair skeletal muscle regeneration by inhibiting myoblast proliferation, reducing myogenic differentiation, and promoting muscular fibrosis

    Scientific Reports, Vol. 11, Núm. 1

2018

  1. Hyperphosphatemia promotes senescence of myoblasts by impairing autophagy through Ilk overexpression, a possible mechanism involved in sarcopenia

    Aging and Disease, Vol. 9, Núm. 5, pp. 769-784

2017

  1. Effects of the catalase antioxidant enzyme in vascular calcification and bone demineralization

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 9, Núm. 1, pp. 13-19

2016

  1. Lamin A is involved in the development of vascular calcification induced by chronic kidney failure and phosphorus load

    Bone, Vol. 84, pp. 160-168

  2. MicroRNAs 29b, 133b, and 211 regulate vascular smooth muscle calcification mediated by high phosphorus

    Journal of the American Society of Nephrology, Vol. 27, Núm. 3, pp. 824-834

2011

  1. Natural antioxidants and vascular calcification: A possible benefit?

    Journal of Nephrology, Vol. 24, Núm. 6, pp. 669-672

2010

  1. High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression

    Bone, Vol. 46, Núm. 1, pp. 121-128